m(6)A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer

Small-cell lung cancer (SCLC) is a devastating subtype of lung cancer with few therapeutic options. Despite the advent of immunotherapy, platinum-based chemotherapy is still the irreplaceable first-line therapy for SCLCs. However, drug resistance will invariably occur in most patients and the outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhihui, Zhang, Chaoqi, Yang, Zhaoyang, Zhang, Guochao, Wu, Peng, Luo, Yuejun, Zeng, Qingpeng, Wang, Lide, Xue, Qi, Zhang, Yi, Sun, Nan, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579518/
https://www.ncbi.nlm.nih.gov/pubmed/34758859
http://dx.doi.org/10.1186/s13045-021-01173-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579518/
https://www.ncbi.nlm.nih.gov/pubmed/34758859
http://dx.doi.org/10.1186/s13045-021-01173-4

Ejemplares similares